Soleno Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$52.25(as of Apr 6, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Soleno Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$52.25
Ticker SymbolSLNO
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees182
CountyUSA
Market Cap$2,121.0M
EBIDTA17.0M
10-Day Moving Average34.95
P/E Ratio135.89
20-Day Moving Average35.30
Forward P/E Ratio9.78
50-Day Moving Average38.16
Earnings per Share0.39
200-Day Moving Average57.18
Profit Margin47.27%
RSI77.80
Shares Outstanding51.6M
ATR3.22
52-Week High90.32
Volume58,033,832
52-Week Low29.43
Most Recent Support Level29.43
Book Value450.1M
Most Recent Resistance Level32.37
P/B Ratio6.31
Upper Keltner42.56
P/S Ratio14.91
Lower Keltner28.05
Debt-to-Equity Ratio42.56
Next Earnings DateUnknown
Cash Surplus8.7M
Next Ex-Dividend DateUnknown

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

Soleno Therapeutics Inc In Our Stock Scanner

As of Apr 07, 2026
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.